Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 43

The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.

Pluripotent Stem Cell Platforms for Drug Discovery

Chen, Kevin G., Mallon, Barbara S., Park, Kyeyoon, Robey, Pamela G., McKay, Ronald D.G., Gottesman, Michael M., Zheng, Wei·2018·Trends in Molecular Medicine

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.molmed.2018.06.009

Cites

21 of 21 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 21 references

Research works printed but not linked: 81

  1. Takahashi, 2007, Induction of pluripotent stem cells from adult human fibroblasts by defined factors, Cell, 131, 861, 10.1016/j.cell.2007.11.019 · DOI · Paper page
  2. Yu, 2007, Induced pluripotent stem cell lines derived from human somatic cells, Science, 318, 1917, 10.1126/science.1151526 · DOI · Paper page
  3. Thomson, 1998, Embryonic stem cell lines derived from human blastocysts, Science, 282, 1145, 10.1126/science.282.5391.1145 · DOI · Paper page
  4. Takahashi, 2006, Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors, Cell, 126, 663, 10.1016/j.cell.2006.07.024 · DOI · Paper page
  5. Chen, 2014, Developmental insights from early mammalian embryos and core signaling pathways that influence human pluripotent cell growth and differentiation, Stem Cell Res., 12, 610, 10.1016/j.scr.2014.02.002 · DOI
  6. Narva, 2010, High-resolution DNA analysis of human embryonic stem cell lines reveals culture-induced copy number changes and loss of heterozygosity, Nat. Biotechnol., 28, 371, 10.1038/nbt.1615 · DOI · Paper page
  7. Draper, 2004, Recurrent gain of chromosomes 17q and 12 in cultured human embryonic stem cells, Nat. Biotechnol., 22, 53, 10.1038/nbt922 · DOI · Paper page
  8. Zhang, 2009, Functional cardiomyocytes derived from human induced pluripotent stem cells, Circ. Res., 104, e30, 10.1161/CIRCRESAHA.108.192237 · DOI · Paper page
  9. Lee, 2010, Induced pluripotent stem cell technology for the study of human disease, Nat. Methods, 7, 25, 10.1038/nmeth.f.283 · DOI
  10. Inoue, 2011, The use of induced pluripotent stem cells in drug development, Clin. Pharmacol. Ther., 89, 655, 10.1038/clpt.2011.38 · DOI · Paper page
  11. Zheng, 2013, Phenotypic screens as a renewed approach for drug discovery, Drug Discov. Today, 18, 1067, 10.1016/j.drudis.2013.07.001 · DOI · Paper page
  12. Ying, 2017, The art of capturing pluripotency: creating the right culture, Stem Cell Rep., 8, 1457, 10.1016/j.stemcr.2017.05.020 · DOI
  13. Tesar, 2007, New cell lines from mouse epiblast share defining features with human embryonic stem cells, Nature, 448, 196, 10.1038/nature05972 · DOI · Paper page
  14. Nichols, 2009, Naive and primed pluripotent states, Cell Stem Cell, 4, 487, 10.1016/j.stem.2009.05.015 · DOI · Paper page
  15. Chen, 2012, Non-colony type monolayer culture of human embryonic stem cells, Stem Cell Res., 9, 237, 10.1016/j.scr.2012.06.003 · DOI
  16. Androutsellis-Theotokis, 2006, Notch signalling regulates stem cell numbers in vitro and in vivo, Nature, 442, 823, 10.1038/nature04940 · DOI · Paper page
  17. Kunova, 2013, Adaptation to robust monolayer expansion produces human pluripotent stem cells with improved viability, Stem Cells Transl. Med., 2, 246, 10.5966/sctm.2012-0081 · DOI
  18. Lee, 2012, Large-scale screening using familial dysautonomia induced pluripotent stem cells identifies compounds that rescue IKBKAP expression, Nat. Biotechnol., 30, 1244, 10.1038/nbt.2435 · DOI · Paper page
  19. Hoing, 2012, Discovery of inhibitors of microglial neurotoxicity acting through multiple mechanisms using a stem-cell-based phenotypic assay, Cell Stem Cell, 11, 620, 10.1016/j.stem.2012.07.005 · DOI
  20. Charbord, 2013, High throughput screening for inhibitors of REST in neural derivatives of human embryonic stem cells reveals a chemical compound that promotes expression of neuronal genes, Stem Cells, 31, 1816, 10.1002/stem.1430 · DOI
  21. Kaufmann, 2015, High-throughput screening using iPSC-derived neuronal progenitors to identify compounds counteracting epigenetic gene silencing in fragile X syndrome, J. Biomol. Screen., 20, 1101, 10.1177/1087057115588287 · DOI · Paper page
  22. Ma, 2011, High purity human-induced pluripotent stem cell-derived cardiomyocytes: electrophysiological properties of action potentials and ionic currents, Am. J. Physiol. Heart Circ. Physiol., 301, H2006, 10.1152/ajpheart.00694.2011 · DOI · Paper page
  23. Harris, 2013, Comparison of electrophysiological data from human-induced pluripotent stem cell-derived cardiomyocytes to functional preclinical safety assays, Toxicol. Sci., 134, 412, 10.1093/toxsci/kft113 · DOI · Paper page
  24. Doherty, 2015, Structural and functional screening in human induced-pluripotent stem cell-derived cardiomyocytes accurately identifies cardiotoxicity of multiple drug types, Toxicol. Appl. Pharmacol., 285, 51, 10.1016/j.taap.2015.03.008 · DOI
  25. Sirenko, 2014, High-content assays for hepatotoxicity using induced pluripotent stem cell-derived cells, Assay Drug Dev. Technol., 12, 43, 10.1089/adt.2013.520 · DOI
  26. Choi, 2013, Efficient drug screening and gene correction for treating liver disease using patient-specific stem cells, Hepatology, 57, 2458, 10.1002/hep.26237 · DOI · Paper page
  27. Ware, 2015, Prediction of drug-induced liver injury in micropatterned co-cultures containing iPSC-derived human hepatocytes, Toxicol. Sci., 145, 252, 10.1093/toxsci/kfv048 · DOI · Paper page
  28. Mathur, 2015, Human iPSC-based cardiac microphysiological system for drug screening applications, Sci. Rep., 5, 8883, 10.1038/srep08883 · DOI · Paper page
  29. Zhang, 2013, Tissue-engineered cardiac patch for advanced functional maturation of human ESC-derived cardiomyocytes, Biomaterials, 34, 5813, 10.1016/j.biomaterials.2013.04.026 · DOI · Paper page
  30. Hinson, 2015, Heart disease. Titin mutations in iPS cells define sarcomere insufficiency as a cause of dilated cardiomyopathy, Science, 349, 982, 10.1126/science.aaa5458 · DOI · Paper page
  31. Carpentier, 2016, Hepatic differentiation of human pluripotent stem cells in miniaturized format suitable for high-throughput screen, Stem Cell Res., 16, 640, 10.1016/j.scr.2016.03.009 · DOI · Paper page
  32. Mullard, 2015, Stem-cell discovery platforms yield first clinical candidates, Nat. Rev. Drug Discov., 14, 589, 10.1038/nrd4708 · DOI
  33. Baker, 2007, Adaptation to culture of human embryonic stem cells and oncogenesis in vivo, Nat. Biotechnol., 25, 207, 10.1038/nbt1285 · DOI · Paper page
  34. Forsyth, 2006, Physiologic oxygen enhances human embryonic stem cell clonal recovery and reduces chromosomal abnormalities, Cloning Stem Cells, 8, 16, 10.1089/clo.2006.8.16 · DOI · Paper page
  35. Herron, 2016, Extracellular matrix-mediated maturation of human pluripotent stem cell-derived cardiac monolayer structure and electrophysiological function, Circ. Arrhythm. Electrophysiol., 9, 10.1161/CIRCEP.113.003638 · DOI · Paper page
  36. Jeziorowska, 2017, Differential sarcomere and electrophysiological maturation of human iPSC-derived cardiac myocytes in monolayer vs. aggregation-based differentiation protocols, Int. J. Mol. Sci., 18, 10.3390/ijms18061173 · DOI
  37. Loirand, 2015, Rho kinases in health and disease: from basic science to translational research, Pharmacol. Rev., 67, 1074, 10.1124/pr.115.010595 · DOI · Paper page
  38. Chen, 2014, Alternative cultures for human pluripotent stem cell production, maintenance, and genetic analysis, J. Vis. Exp., 89, 51519
  39. Braam, 2008, Improved genetic manipulation of human embryonic stem cells, Nat. Methods, 5, 389, 10.1038/nmeth.1200 · DOI
  40. Liew, 2007, Transient and stable transgene expression in human embryonic stem cells, Stem Cells, 25, 1521, 10.1634/stemcells.2006-0634 · DOI
  41. Padmanabhan, 2012, Regulation and expression of the ATP-binding cassette transporter ABCG2 in human embryonic stem cells, Stem Cells, 30, 2175, 10.1002/stem.1195 · DOI
  42. Xia, 2013, Directed differentiation of human pluripotent cells to ureteric bud kidney progenitor-like cells, Nat. Cell Biol., 15, 1507, 10.1038/ncb2872 · DOI · Paper page
  43. Mummery, 2003, Differentiation of human embryonic stem cells to cardiomyocytes: role of coculture with visceral endoderm-like cells, Circulation, 107, 2733, 10.1161/01.CIR.0000068356.38592.68 · DOI · Paper page
  44. Cimetta, 2009, Micro-bioreactor arrays for controlling cellular environments: design principles for human embryonic stem cell applications, Methods, 47, 81, 10.1016/j.ymeth.2008.10.015 · DOI
  45. Villa-Diaz, 2009, Microfluidic culture of single human embryonic stem cell colonies, Lab Chip, 9, 1749, 10.1039/b820380f · DOI
  46. Moledina, 2012, Predictive microfluidic control of regulatory ligand trajectories in individual pluripotent cells, Proc. Natl. Acad. Sci. U. S. A., 109, 3264, 10.1073/pnas.1111478109 · DOI
  47. van der Meer, 2013, Three-dimensional co-cultures of human endothelial cells and embryonic stem cell-derived pericytes inside a microfluidic device, Lab Chip, 13, 3562, 10.1039/c3lc50435b · DOI
  48. Dutta, 2017, Disease modeling in stem cell-derived 3D organoid systems, Trends Mol. Med., 23, 393, 10.1016/j.molmed.2017.02.007 · DOI · Paper page
  49. Koo, 2016, Organoids: a new in vitro model system for biomedical science and disease modelling and promising source for cell-based transplantation, Dev. Biol., 420, 197, 10.1016/j.ydbio.2016.10.017 · DOI
  50. Takebe, 2014, Generation of a vascularized and functional human liver from an iPSC-derived organ bud transplant, Nat. Protoc., 9, 396, 10.1038/nprot.2014.020 · DOI · Paper page
  51. Lancaster, 2013, Cerebral organoids model human brain development and microcephaly, Nature, 501, 373, 10.1038/nature12517 · DOI · Paper page
  52. Watson, 2014, An in vivo model of human small intestine using pluripotent stem cells, Nat. Med., 20, 1310, 10.1038/nm.3737 · DOI · Paper page
  53. Dye, 2015, In vitro generation of human pluripotent stem cell derived lung organoids, Elife, 4, 10.7554/eLife.05098 · DOI · Paper page
  54. Xu, 2016, Identification of small-molecule inhibitors of Zika virus infection and induced neural cell death via a drug repurposing screen, Nat. Med., 22, 1101, 10.1038/nm.4184 · DOI · Paper page
  55. Chen, 2017, Mouse genetic analysis of bone marrow stem cell niches: technological pitfalls, challenges, and translational considerations, Stem Cell Rep., 9, 1343, 10.1016/j.stemcr.2017.09.014 · DOI
  56. Scadden, 2014, Nice neighborhood: emerging concepts of the stem cell niche, Cell, 157, 41, 10.1016/j.cell.2014.02.013 · DOI · Paper page
  57. Schofield, 1978, The relationship between the spleen colony-forming cell and the haemopoietic stem cell, Blood Cells, 4, 7
  58. Chen, 2018, Concise review: conceptualizing paralogous stem-cell niches and unfolding bone marrow progenitor cell identities, Stem Cells, 36, 11, 10.1002/stem.2711 · DOI
  59. Ootani, 2009, Sustained in vitro intestinal epithelial culture within a Wnt-dependent stem cell niche, Nat. Med., 15, 701, 10.1038/nm.1951 · DOI · Paper page
  60. Sato, 2009, Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche, Nature, 459, 262, 10.1038/nature07935 · DOI · Paper page
  61. Zaret, 2002, Regulatory phases of early liver development: paradigms of organogenesis, Nat. Rev. Genet., 3, 499, 10.1038/nrg837 · DOI · Paper page
  62. Chawla, 2001, Nuclear receptors and lipid physiology: opening the X-files, Science, 294, 1866, 10.1126/science.294.5548.1866 · DOI · Paper page
  63. Guengerich, 2008, Cytochrome p450 and chemical toxicology, Chem. Res. Toxicol., 21, 70, 10.1021/tx700079z · DOI · Paper page
  64. Caswell, 2013, Engineering and application of P450 monooxygenases in pharmaceutical and metabolite synthesis, Curr. Opin. Chem. Biol., 17, 271, 10.1016/j.cbpa.2013.01.028 · DOI
  65. Wlcek, 2014, ATP-binding cassette transporters in liver, Biofactors, 40, 188, 10.1002/biof.1136 · DOI
  66. Gottesman, 2002, Multidrug resistance in cancer: role of ATP-dependent transporters, Nat. Rev. Cancer, 2, 48, 10.1038/nrc706 · DOI · Paper page
  67. Borst, 2002, Mammalian ABC transporters in health and disease, Annu. Rev. Biochem., 71, 537, 10.1146/annurev.biochem.71.102301.093055 · DOI · Paper page
  68. Dean, 2005, Evolution of the ATP-binding cassette (ABC) transporter superfamily in vertebrates, Annu. Rev. Genomics Hum. Genet., 6, 123, 10.1146/annurev.genom.6.080604.162122 · DOI · Paper page
  69. Chen, 2012, Molecular pathways: regulation and therapeutic implications of multidrug resistance, Clin. Cancer Res., 18, 1863, 10.1158/1078-0432.CCR-11-1590 · DOI · Paper page
  70. Szakacs, 2006, Targeting multidrug resistance in cancer, Nat. Rev. Drug Discov., 5, 219, 10.1038/nrd1984 · DOI · Paper page
  71. Burger, 2004, Pharmacokinetic resistance to imatinib mesylate: role of the ABC drug pumps ABCG2 (BCRP) and ABCB1 (MDR1) in the oral bioavailability of imatinib, Cell Cycle, 3, 1502, 10.4161/cc.3.12.1331 · DOI
  72. Burger, 2004, Imatinib mesylate (STI571) is a substrate for the breast cancer resistance protein (BCRP)/ABCG2 drug pump, Blood, 104, 2940, 10.1182/blood-2004-04-1398 · DOI · Paper page
  73. Chen, 1997, Multidrug-resistant human sarcoma cells with a mutant P-glycoprotein, altered phenotype, and resistance to cyclosporins, J. Biol. Chem., 272, 5974, 10.1074/jbc.272.9.5974 · DOI
  74. Chen, 2000, Loss of cyclosporin and azidopine binding are associated with altered ATPase activity by a mutant P-glycoprotein with deleted phe(335), Mol. Pharmacol., 57, 769, 10.1124/mol.57.4.769 · DOI
  75. Loo, 2005, Recent progress in understanding the mechanism of P-glycoprotein-mediated drug efflux, J. Membr. Biol., 206, 173, 10.1007/s00232-005-0792-1 · DOI · Paper page
  76. Ambudkar, 1999, Biochemical, cellular, and pharmacological aspects of the multidrug transporter, Annu. Rev. Pharmacol. Toxicol., 39, 361, 10.1146/annurev.pharmtox.39.1.361 · DOI · Paper page
  77. Kimchi-Sarfaty, 2007, A “silent” polymorphism in the MDR1 gene changes substrate specificity, Science, 315, 525, 10.1126/science.1135308 · DOI · Paper page
  78. Dekkers, 2013, A functional CFTR assay using primary cystic fibrosis intestinal organoids, Nat. Med., 19, 939, 10.1038/nm.3201 · DOI · Paper page
  79. Firth, 2015, Functional gene correction for cystic fibrosis in lung epithelial cells generated from patient iPSCs, Cell Rep., 12, 1385, 10.1016/j.celrep.2015.07.062 · DOI · Paper page
  80. Castellani, 2008, Consensus on the use and interpretation of cystic fibrosis mutation analysis in clinical practice, J. Cyst. Fibros., 7, 179, 10.1016/j.jcf.2008.03.009 · DOI · Paper page
  81. Dujardin, 2011, Splicing defects in the CFTR gene: minigene analysis of two mutations, 1811+1G>C and 1898+3A>G, J. Cyst. Fibros., 10, 212, 10.1016/j.jcf.2010.12.008 · DOI

Cited by

See all 43

Metadata

Authors
Chen, K. G., Mallon, B. S., Park, K., Robey, P. G., McKay, R. D. G., Gottesman, M. M., & Zheng, W.
Venue
Trends in Molecular Medicine
Publisher
Elsevier BV
Published
2018-09
Volume
24
Issue
9
Pages
805-820
ISSN
1471-4914
Cited by
43
References
21
Language
en
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Pluripotent Stem Cell Platforms for Drug Discovery. https://app.cochat.ai/papers/10.1016/j.molmed.2018.06.009
The paper
Chen, K. G., Mallon, B. S., Park, K., Robey, P. G., McKay, R. D. G., Gottesman, M. M., & Zheng, W. (2018). Pluripotent Stem Cell Platforms for Drug Discovery. Trends in Molecular Medicine. https://doi.org/10.1016/j.molmed.2018.06.009

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.